株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

インフルエンザ診断の世界市場:検査の種類別・エンドユース別・地域別 - 市場分析、シェア、動向、規模、予測 (2020~2026年)

Influenza Diagnostics Market, By Test Type, by End Use, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026

発行 AnalystView Market Insights 商品コード 941388
出版日 ページ情報 英文 169 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。
インフルエンザ診断の世界市場:検査の種類別・エンドユース別・地域別 - 市場分析、シェア、動向、規模、予測 (2020~2026年) Influenza Diagnostics Market, By Test Type, by End Use, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026
出版日: 2020年06月01日 ページ情報: 英文 169 Pages
概要

世界のインフルエンザ診断の市場規模は、2019年には28億3000万米ドルに達し、更に2020~2026年にかけて6.1%のCAGRで成長する見通しです。

当レポートでは、世界のインフルエンザ診断の市場について分析し、市場の定義や基本構造、主な市場促進・抑制要因、業界の競争力・求心力、市場シェア構造、検査の種類別・エンドユース別・地域別の市場動向見通し (過去4年間・今後8年間分)、主要企業のプロファイルなどについて調査しております。

第1章 インフルエンザ診断市場の概要

第2章 エグゼクティブサマリー

第3章 インフルエンザ診断:主な市場動向

  • 市場促進要因
    • 市場促進要因の影響度の分析
  • 市場抑制要因
    • 市場抑制要因の影響度の分析
  • 市場機会
  • 将来の市場動向

第4章 インフルエンザ診断:産業研究

  • ポーターのファイブフォース分析
  • マーケティング戦略分析
  • パイプライン分析(潜在的な第III相候補)
  • 市場成長の見通し:マッピング
  • 規制体制の分析
  • 新型コロナウイルス感染症 (Covid-19) の影響の分析
    • Covid-19以前の影響分析
    • Covid-19以降の影響分析

第5章 インフルエンザ診断:市場環境

  • 市場シェア分析
  • 主な技術革新企業 (イノベーター)
  • 市場区分データ:主要メーカー別
    • 既存企業の分析
    • 新規企業の分析

第6章 インフルエンザ診断市場:検査の種類別

  • 概要
    • 市場シェア分析:検査の種類別 (2019年、2026年)
  • RIDT (インフルエンザ迅速診断)
    • 概観
    • 市場の分析・予測、対前年比成長率 (金額ベース、2015~2026年)
  • RT-PCR (逆転写ポリメラーゼ連鎖反応)
  • 細胞培養
  • その他

第7章 インフルエンザの診断市場:エンドユース別

  • 概観
    • 市場シェア分析:エンドユース別 (2019年、2026年)
  • 病院
  • POCT (ポイントオブケア診断)
  • 臨床検査室
  • その他

第8章 インフルエンザの診断市場:地域別

  • イントロダクション
    • 市場シェア分析:地域別 (2019年、2026年)
  • 北米
    • 概観
    • 米国
    • カナダ
  • 欧州
    • 概観
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • その他の欧州諸国
  • アジア太平洋地域
    • 概観
    • インド
    • 中国
    • 日本
    • 韓国
    • その他のアジア太平洋地域諸国
  • ラテンアメリカ
    • 概観
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他のラテンアメリカ諸国
  • 中東とアフリカ
    • 概観
    • サウジアラビア
    • アラブ首長国連邦 (UAE)

第9章 主要ベンダーの分析

  • Quidel Corporation
    • 企業概況
    • 財務実績
    • 製品の相互比較
    • 戦略展開状況
  • Alere, Inc.
  • Roche Diagnostics
  • Siemens Healthineers
  • Abbott Laboratories
  • Dickinson and Company
  • Becton
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories, Inc.

第10章 アナリストの全方位的分析

第11章 付録

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Influenza Diagnostics market: Test Type Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Test Type
  • TABLE Global Influenza Diagnostics market, by Test Type 2015-2026 (USD Million)
  • TABLE Influenza Diagnostics market: End Use Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by End Use
  • TABLE Global Influenza Diagnostics market, by End Use 2015-2026 (USD Million)
  • TABLE Influenza Diagnostics market: Regional snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Influenza Diagnostics market, by Region 2015-2026 (USD Million)
  • TABLE North America Influenza Diagnostics market, by Country, 2015-2026 (USD Million)
  • TABLE North America Influenza Diagnostics market, by Test Type, 2015-2026 (USD Million)
  • TABLE North America Influenza Diagnostics market, by End Use, 2015-2026 (USD Million)
  • TABLE Europe Influenza Diagnostics market, by country, 2015-2026 (USD Million)
  • TABLE Europe Influenza Diagnostics market, by Test Type, 2015-2026 (USD Million)
  • TABLE Europe Influenza Diagnostics market, by End Use, 2015-2026 (USD Million)
  • TABLE Asia Pacific Influenza Diagnostics market, by country, 2015-2026 (USD Million)
  • TABLE Asia Pacific Influenza Diagnostics market, by Test Type, 2015-2026 (USD Million)
  • TABLE Asia Pacific Influenza Diagnostics market, by End Use, 2015-2026 (USD Million)
  • TABLE Latin America Influenza Diagnostics market, by country, 2015-2026 (USD Million)
  • TABLE Latin America Influenza Diagnostics market, by Test Type, 2015-2026 (USD Million)
  • TABLE Latin America Influenza Diagnostics market, by End Use, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Influenza Diagnostics market, by country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Influenza Diagnostics market, by Test Type, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Influenza Diagnostics market, by End Use, 2015-2026 (USD Million)

List of Figures

  • FIGURE Influenza Diagnostics market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Test Type segment market share analysis, 2019 & 2026
  • FIGURE Test Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rapid Influenza Diagnostic Tests (RIDT) segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Reverse Transcription Polymerase Chain Reaction (RT-PCR) segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Cell Culture segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Others segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE End Use segment market share analysis, 2019 & 2026
  • FIGURE End Use segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Hospitals segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Point of Care Testing (POCT) segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Clinical Laboratories segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Others segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Regional segment market share analysis, 2019 & 2026
  • FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE North America Influenza Diagnostics market share and leading players, 2018
  • FIGURE Europe Influenza Diagnostics market share and leading players, 2018
  • FIGURE Asia Pacific Influenza Diagnostics market share and leading players, 2018
  • FIGURE Latin America Influenza Diagnostics market share and leading players, 2018
  • FIGURE Middle East and Africa Influenza Diagnostics market share and leading players, 2018
  • FIGURE North America Influenza Diagnostics market share analysis by country, 2018
  • FIGURE U.S. Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Canada Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Europe Influenza Diagnostics market share analysis by country, 2018
  • FIGURE Germany Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spain Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Italy Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE UK Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE France Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of the Europe Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Asia Pacific Influenza Diagnostics market share analysis by country, 2018
  • FIGURE India Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE China Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Japan Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE South Korea Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Singapore Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of APAC Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Influenza Diagnostics market share analysis by country, 2018
  • FIGURE Brazil Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Mexico Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Argentina Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of LATAM Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Influenza Diagnostics market share analysis by country, 2018
  • FIGURE Saudi Arabia Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE United Arab Emirates Influenza Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)
目次

REPORT HIGHLIGHT

Influenza diagnostics market was valued at USD 2.83 billion by 2019, growing with 6.1% CAGR during the forecast period, 2020-2026

Market Dynamics

The growing prevalence of chronic diseases such as blood disorder, heart disorders, and diabetes and the increasing geriatric population all across the globe are the major factors boosting the growth of the global influenza diagnostics market. In addition, the emergence of advancements in technology for diagnostic tests and increasing government initiatives for countering influenza are other factors impelling market growth.

The immunosuppresses individuals, especially those suffering from chronic diseases, are more susceptible to influenza and thus, the demand for influenza diagnostic products is been increasing. The data presented by Centers for Disease Control and Prevention (CDC), approximately 85 laboratory-confirmed paediatric deaths were witnessed in Puerto Rico, District of Columbia, and 33 other states. In 2016, the mortality due to influenza in the U.S. was 4,605, which indicated 1.4 deaths per 100,000 individuals. However, the mutation of the virus serotype is predicted to hinder the market growth during the forecast period.

Test Type Takeaway

The rapid influenza diagnostic tests (RIDT) segment accounted for the largest market share in 2019 and is expected to grow at a healthy growth rate during the forecast period. This is mainly because these test types are frequently used for the diagnosis of influenza. Moreover, RIDT is considered as the gold standard test working for the diagnosis of influenza and delivers quick results, which is further estimated to dominate the global market by 2030. On the other hand, the cell culture test type is commonly considered as a reference method and is extensively used when the incidence rate of the disease is being tested. This test type provides accurate statistics along with an ability to precisely distinguish between the several types of influenza viruses. Thus, the cell culture segment is estimated to grow at an impressive growth rate during the period of forecast.

End Use Takeaway

The hospitals end-use segment for overall influenza diagnostics registered for the majority of market share in 2019 and is projected to steadily slow down owing to the advent of POCT laboratories as these laboratories deliver accurate results. Thus, the POCT end use segment is anticipated to grow at the fastest growth rate by 2030 owing to its ease of use and advantage that it can be used by anyone without any requirement for expertise. In addition, with the advent POCT of advanced technology, the reliance of the physicians and the public on these tests has increased significantly.

REGIONAL TAKEAWAY

Presently, the North America region is leading the overall influenza diagnostics market attributing to a strong focus of the CDC on regulating the disease rates. Additionally, the high technological advancements in this region coupled with the rising healthcare spending are projected to propel the regional market growth by 2030. On the other hand, the Asia Pacific market for influenza diagnostics is projected to witness the fastest growth owing to factors such as significant disease burden and high population density in the region.

Key players of the market include:

  • Quidel Corporation
  • Alere, Inc.
  • Roche Diagnostics
  • Siemens Healthineers
  • Abbott Laboratories
  • Dickinson and Company
  • Becton
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories, Inc.

The market size and forecast for each segment and sub-segments has been considered as below:

  • Historical Year - 2015 to 2018
  • Base Year - 2019
  • Estimated Year - 2020
  • Projected Year - 2026

TARGET AUDIENCE

  • Traders, Distributors, and Suppliers
  • Manufacturers
  • Government and Regional Agencies
  • Research Organizations
  • Consultants
  • Distributors

Scope of the Report

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE

  • Rapid Influenza Diagnostic Tests (RIDT)
  • Reverse Transcription Polymerase Chain Reaction (RT-PCR)
  • Cell Culture
  • Others

GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY END USE

  • Hospitals
  • Point of Care Testing (POCT)
  • Clinical Laboratories
  • Others

GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Singapore
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Rest of MEA

TABLE OF CONTENT

1. INFLUENZA DIAGNOSTICS MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Test Type
    • 2.1.2. Market Snippet by End Use
    • 2.1.3. Market Snippet by Region
  • 2.2. Competitive Insights

3. INFLUENZA DIAGNOSTICS KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. INFLUENZA DIAGNOSTICS INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Pipeline Analysis (Potential Phase III Candidates)
  • 4.4. Growth Prospect Mapping
  • 4.5. Regulatory Framework Analysis
  • 4.6. COVID-19 Impact Analysis
    • 4.6.1. Pre-COVID-19 Impact Analysis
    • 4.6.2. Post-COVID-19 Impact Analysis

5. INFLUENZA DIAGNOSTICS MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. INFLUENZA DIAGNOSTICS MARKET - BY TEST TYPE

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Test Type, 2019 & 2026 (%)
  • 6.2. Rapid Influenza Diagnostic Tests (RIDT)
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.3. Reverse Transcription Polymerase Chain Reaction (RT-PCR)
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.4. Cell Culture
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.5. Others
    • 6.5.1. Overview
    • 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. INFLUENZA DIAGNOSTICS MARKET - BY END USE

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By End Use, 2019 & 2026 (%)
  • 7.2. Hospitals
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.3. Point of Care Testing (POCT)
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.4. Clinical Laboratories
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.5. Others
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. INFLUENZA DIAGNOSTICS MARKET- BY GEOGRAPHY

  • 8.1. Introduction
    • 8.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
  • 8.2. North America
    • 8.2.1. Overview
    • 8.2.2. Key Manufacturers in North America
    • 8.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 8.2.4. North America Market Size and Forecast, By Test Type, 2015 - 2026 (US$ Million)
    • 8.2.5. North America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 8.2.6. U.S.
      • 8.2.6.1. Overview
      • 8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.2.7. Canada
      • 8.2.7.1. Overview
      • 8.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.3. Europe
    • 8.3.1. Overview
    • 8.3.2. Key Manufacturers in Europe
    • 8.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 8.3.4. Europe Market Size and Forecast, By Test Type, 2015 - 2026 (US$ Million)
    • 8.3.5. Europe Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 8.3.6. Germany
      • 8.3.6.1. Overview
      • 8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.3.7. Italy
      • 8.3.7.1. Overview
      • 8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.3.8. United Kingdom
      • 8.3.8.1. Overview
      • 8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.3.9. France
      • 8.3.9.1. Overview
      • 8.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.3.10. Rest of Europe
      • 8.3.10.1. Overview
      • 8.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.4. Asia Pacific (APAC)
    • 8.4.1. Overview
    • 8.4.2. Key Manufacturers in Asia Pacific
    • 8.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 8.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2015 - 2026 (US$ Million)
    • 8.4.5. Asia Pacific Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 8.4.6. India
      • 8.4.6.1. Overview
      • 8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.4.7. China
      • 8.4.7.1. Overview
      • 8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.4.8. Japan
      • 8.4.8.1. Overview
      • 8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.4.9. South Korea
      • 8.4.9.1. Overview
      • 8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.4.10. Rest of APAC
      • 8.4.10.1. Overview
      • 8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.5. Latin America
    • 8.5.1. Overview
    • 8.5.2. Key Manufacturers in Latin America
    • 8.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 8.5.4. Latin America Market Size and Forecast, By Test Type, 2015 - 2026 (US$ Million)
    • 8.5.5. Latin America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 8.5.6. Brazil
      • 8.5.6.1. Overview
      • 8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.5.7. Mexico
      • 8.5.7.1. Overview
      • 8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.5.8. Argentina
      • 8.5.8.1. Overview
      • 8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.5.9. Rest of LATAM
      • 8.5.9.1. Overview
      • 8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Overview
    • 8.6.2. Key Manufacturers in Middle East and Africa
    • 8.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 8.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2015 - 2026 (US$ Million)
    • 8.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)
    • 8.6.6. Saudi Arabia
      • 8.6.6.1. Overview
      • 8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 8.6.7. United Arab Emirates
      • 8.6.7.1. Overview
      • 8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9. KEY VENDOR ANALYSIS

  • 9.1. Quidel Corporation
    • 9.1.1. Company Snapshot
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Strategic Initiatives
  • 9.2. Alere, Inc.
  • 9.3. Roche Diagnostics
  • 9.4. Siemens Healthineers
  • 9.5. Abbott Laboratories
  • 9.6. Dickinson and Company
  • 9.7. Becton
  • 9.8. Thermo Fisher Scientific
  • 9.9. Bio-Rad Laboratories, Inc.

10. 360 DEGREE ANALYSTVIEW

11. APPENDIX

  • 11.1. Research Methodology
  • 11.2. References
  • 11.3. Abbreviations
  • 11.4. Disclaimer
  • 11.5. Contact Us